AIDS Vaccine Week articles from March 2009

AIDS Vaccine Week archives from March 2009

OHSU vaccine research targets HIV in the slower, early stage of infection.(Report)
March 2, 2009... New research at Oregon Health & Science University's Vaccine and Gene Therapy Institute suggests vaccines that specifically target HIV in the initial stages of infection before it becomes a rapidly replicating, system-wide infection - may be a...

New acute viremia study findings have been published by scientists at National Institutes of Health.
March 2, 2009... "Cell-mediated immunity and neutralizing antibodies contribute to control of human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV) infection, but the role of nonneutralizing antibodies is not defined. Previously, we reported that...

New findings reported from University of Massachusetts, Medical Department describe advances in DNA vaccines.
March 2, 2009... "After more than 30 years of research a HIV vaccine is still not at hand. DNA vectors expressing viral antigens are very safe vaccines, but so far they have not been efficient enough to induced broad protective immunity against retroviruses,"...

Data on HIV/AIDS published by researchers at National Institutes of Health.
March 2, 2009... "During human immunodeficiency virus type 1 (HIV-1) infection, patients develop various levels of neutralizing antibody (NAb) responses. In some cases, patient sera can potently neutralize diverse strains of HIV-1, but the antibody...

Investigators at National Institutes of Health zero in on HIV/AIDS.(Report)
March 2, 2009... According to recent research from the United States, "Human immunodeficiency virus type 1 (HIV-1) infection is characterized by the rapid onset of intestinal T-cell depletion that initiates the progression to AIDS. The induction of protective...

Research from A. Morner and colleagues has provided new data on HIV/AIDS.
March 2, 2009... According to a study from Stockholm, Sweden, "Currently there is limited information about the quality of immune responses elicited by candidate human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env)-based immunogens in...

Research from Johns Hopkins University in HIV/AIDS provides new insights.
March 2, 2009... "The glycosylation state of envelope glycoproteins in human and simian immunodeficiency viruses (HIV/SIV) is critical to viral infectivity and tropism, viral protein processing, and in virus evasion of the immune system. Using a rapid...

Studies from K. Kaushik and colleagues provide new data on HIV/AIDS.
March 2, 2009... "We compared the lymphoproliferative and cytokine responses to Cryptosporidium parvum in human immunodeficiency virus (HIV)-seropositive and -seronegative patients. The lymphoproliferative and cytokine responses (interleukin-2 [IL-2], IL-4,...

Study data from E. Carnero and co-authors update knowledge of HIV/AIDS.
March 2, 2009... "One attractive strategy for the development of a human immunodeficiency virus (HIV) vaccine is the use of viral vectors with a proven safety profile and an absence of preexisting immunity in humans, such as Newcastle disease virus (NDV)....

Study findings from D.N. Sather et al provide new insights into HIV/AIDS.
March 2, 2009... According to a study from the United States, "The characterization of the cross-reactive, or heterologous, neutralizing antibody responses developed during human immunodeficiency virus type 1 (HIV-1) infection and the identification of factors...

Study data from University of London provide new insights into HIV/AIDS co-infection.
March 2, 2009... According to a study from London, the United Kingdom, "This paper summarises tuberculosis (TB) research over almost 30 years in Karonga District, northern Malawi, an area typical of much of rural Africa. The dominant factor has been the human...

Research from M.S. Gardner and co-researchers in the area of life sciences published.
March 2, 2009... "Defensins are highly basic cationic peptides that are important components of the innate and adaptive immune response pathways. In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among...

New gene therapy study results from E.S. Gabitzsch et al described.
March 2, 2009... Researchers detail in 'A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses,' new data in gene therapy. According to recent research from the United States,...

Data from New England Medical Center provide new insights into life sciences.(Report)
March 2, 2009... New research, 'Health of children adopted from Ethiopia,' is the subject of a report. "Since 2000, American families have adopted 1,700 children from Ethiopia. Little is known about the health and development of these children," investigators...

NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners.(Awards list)
March 2, 2009... NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Award program, which honors outstanding technological achievements of Northeast Ohio innovators who are impacting the lives of...

New findings from A. Duda and co-researchers in the area of HIV/AIDS described.(Clinical report)
March 9, 2009... According to recent research published in the Journal of Virology, "Human immunodeficiency virus type 1 (HIV-1) can evade immunity shortly after transmission to a new host but the clinical significance of this early viral adaptation in HIV...

New HIV/AIDS study findings have been reported by D. Djokic and colleagues.
March 9, 2009... "High HIV infection rates in the United States are increasingly due to heterosexual risk behaviors, with increased rates in blacks and women. A survey of HIV knowledge and attitudes about HIV testing was conducted in an inner-city public...

New HIV/AIDS study results from University of California described.
March 9, 2009... "A vaccine for the prevention of human immunodeficiency virus (HIV) infection is desperately needed to control the AIDS pandemic. To address this problem, we developed vesicular stomatitis virus glycoprotein-pseudotyped replication-defective...

Researchers from University of London describe findings in HIV/AIDS.
March 9, 2009... "In the absence of a protective vaccine against human immunodeficiency virus (HIV), there is an urgent need for the development of effective topical microbicides to prevent HIV infection. Candidate vaginal microbicides should provide protection...

Studies from N.S. Ryder et al have provided new data on HIV/AIDS co-infection.
March 9, 2009... According to recent research published in the journal Expert Opinion on Investigational Drugs, "Twelve drugs related to therapy and/or prevention of infectious diseases were discontinued from development during 2007." "All of these agents...

New lentivirus infections findings from P. Polacino and co-researchers published.
March 9, 2009... According to a study from the United States, "Differential pathogenicity has been observed in cynomolgus and rhesus macaques following primate lentivirus infection. However, little is known about the comparative susceptibility of pig-tailed...

New smallpox vaccines study findings have been published by scientists at Wadsworth Center.
March 9, 2009... "Smallpox vaccines based on replicating vaccinia virus are known to elicit rare yet serious adverse events, particularly in human populations with immune deficiency, atopic dermatitis and at the extremes of age. A vaccine that induces...

New HIV/AIDS vaccines study results from Uganda Virus Research Institute described.
March 9, 2009... Investigators publish new data in the report 'Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.' In this recently published article, scientists in Entebbe, Uganda conducted a study...

ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs.
March 9, 2009... ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the 16th Conference on Retroviruses and Opportunistic Infections held last week in Montreal....

Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched.
March 9, 2009... The Clearinghouse on Male Circumcision for HIV Prevention -- www.malecircumcison.org -- was launched today. The Web site is designed to generate and share authoritative information about the role of male circumcision in HIV prevention (see also...

ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria.
March 9, 2009... ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed a collaborative agreement with the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), in Maryland, USA. The...

International Partnership for Microbicides Receives US $130 Million from UK Government and the Gates Foundation.
March 9, 2009... The International Partnership for Microbicides (IPM) announced that it has received a total of US $130 million in grants from the UK Department for International Development (DFID) and the Bill & Melinda Gates Foundation, reinforcing the global...

UN Reception Highlights Multi-Sector Partnerships in Global Public Health.
March 9, 2009... Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today,...

NBA and WBNA Help Teens Take Their Best Shot at Health with New Vaccines for Teens Educational Campaign.
March 9, 2009... The National Basketball Association (NBA) and the Women's National Basketball Association (WNBA), in collaboration with the Society for Adolescent Medicine (SAM) and sanofi pasteur (the vaccines division of the sanofi-aventis ...

Scientists at University of East London release new data on gonorrhea.(Report)
March 16, 2009... "In Russia the diagnosis of gonorrhoea in women relied on microscopy, justified by the hypothesis that sensitivity increases using 'provocation' techniques. The aim was to test the value of Gonovaccine as provocation in women who would have...

HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science.
March 16, 2009... A group of leading HIV experts call for the exploration of a new approach to treating HIV - one that could ultimately help eradicate the virus - through a collaboration involving academia, industry, government and patient advocates. This new...

New vaccines research from University of Kansas described.(Clinical report)
March 16, 2009... According to a study from the United States, "Live-attenuated viruses derived from SIV and SHIV have provided the most consistent protection against challenge with pathogenic viruses, but concerns regarding their long-term safety and efficacy...

Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting.
March 16, 2009... Following the completion of the Phase II clinical development of IMVAMUNE(R), a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a success...

Researchers' new goal: Drug-free remission for HIV infection.
March 23, 2009... A group including leading academic and industry scientists has issued a challenge to researchers in the field of HIV/AIDS: find a way to effectively purge latent HIV infection and eliminate the need for chronic, suppressive therapy to control...

Reports from Pohang University of Science and Technology add new data to research in adenovirus.
March 23, 2009... According to recent research from South Korea, "We investigated the immunogenicity and efficacy of a bimodal prime/boost vaccine regimen given by various routes in the Simian immunodeficiency virus (SIV) rhesus monkey model for AIDS. Twelve...

Research conducted at University of Kansas has provided new information about HIV/AIDS.(Report)
March 23, 2009... According to a study from the United States, "The simian-human immunodeficiency virus (SHIV)/macaque model for human immunodeficiency virus type 1 has become a useful tool to assess the role of accessory genes in lentiviral pathogenesis. In...

Research from University Hospital provides new data on HIV/AIDS.
March 23, 2009... According to a study from Bern, Switzerland, "Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency virus (HIV)-infected patients, and adequate immunogenicity and safety are of concern in this population. In...

Research on HIV/AIDS reported by S. Mendiratta et al.
March 23, 2009... "Cytotoxic T lymphocyte (CTL) responses to Gag have been most frequently linked to control of viremia whereas CTL responses to Nef have direct relationship with viral load. IFN-gamma ELISpot assay was used to screen CTL responses at single...

New HIV/AIDS co-infection vaccines findings from Centers for Disease Control and Prevention published.(Report)
March 23, 2009... Investigators publish new data in the report 'Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.' "Hepatitis B vaccination and...

Reports outline pneumonia study results from University of the Witwatersrand, Department of Medicine.
March 23, 2009... Fresh data on pneumonia are presented in the report 'New insights into pneumococcal disease.' "Streptococcus pneumoniae (pneumococcus) remains a common cause of disease and death throughout the world. Despite considerable research into various...

Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS.
March 23, 2009... Aethlon Medical, Inc. (OTCBB:AEMD) announced results of the ofirst-in-mano study of the Aethlon Hemopurifier[R] to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, viral...

R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges.
March 23, 2009... Despite the nation's economic slowdown, America's pharmaceutical research and biotechnology companies invested a record $65.2 billion last year in the research and development of new life-changing medicines and vaccines - an increase of roughly...

HIV adapts to escape immune response.
March 23, 2009... The human immunodeficiency virus (HIV) adapts so well to the body's defense system that any successful AIDS vaccine must keep pace with the ever-changing immunological profile of the virus, according to researchers at the University of Alabama...

Inhibitex Reports Fourth Quarter and Calendar Year 2008 Financial Results and Highlights.(Calendar)
March 23, 2009... Inhibitex, Inc. (NASDAQ: INHX) announced its financial results for the fourth quarter and year ended December 31, 2008 (see also Inhibitex, Inc.). oWe are pleased with the progress we have made over the last year, resulting in the...

GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results.(Financial report)
March 23, 2009... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company focused on development of an HIV/AIDS vaccine, announced its financial results for the fourth quarter and year ended December 31, 2008, and provided a summary...

New HIV/AIDS data have been reported by researchers at University of Pittsburgh.(Report)
March 30, 2009... "In preparation for a pilot clinical trial in patients with chronic human immunodeficiency virus type 1 (HIV-1) infection, a novel dendritic cell (DC)-based vaccine is being manufactured. The trial will test the hypothesis that isolated...

Report summarizes HIV/AIDS study findings from California Institute of Technology.
March 30, 2009... According to a study from the United States, "Broadly neutralizing anti-HIV antibodies are rare and have proved hard to elicit with any immunogen. We have tested in vitro the notion that such antibodies or other antiviral proteins could be made...

Reports by M.J. Boaz and co-researchers describe recent advances in HIV/AIDS.(Report)
March 30, 2009... According to recent research from the United States, "The gamma interferon (IFN-gamma) enzyme- linked immunospot (ELISPOT) assay is used routinely to evaluate the potency of human immunodeficiency virus (HIV) vaccine candidates and other...

Reports from Charite University advance knowledge in HIV/AIDS.(Report)
March 30, 2009... In this recent article published in the journal AIDS, scientists in Berlin, Germany conducted a study "Toll-like receptors (TLRs) play an important role in the innate immune response to pathogens. TLR7 recognizes RNA of various viruses...

Research from University of California provides new data on HIV/AIDS.
March 30, 2009... According to a study from the United States, "A vaccine for human immunodeficiency virus (HIV) infection is desperately needed to control the AIDS pandemic. To address this problem, we constructed single-cycle simian immunodeficiency viruses...

Research from Y.Y.E. Wang and co-authors provides new data about HIV/AIDS.(Report)
March 30, 2009... According to recent research from the United States, "The control of human immunodeficiency virus type 1 (HIV-1) associated with particular HLA class I alleles suggests that some CD8(+) T-cell responses may be more effective than others at...

Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting.(Conference news)
March 30, 2009... Keystone Symposia on Molecular and Cellular Biology will mark the 25th anniversary of its first HIV/AIDS meeting in 1984 when it convenes its scientific conferences on "Prevention of HIV/AIDS" and "HIV Immunobiology: From Infection to Immune...